Evidence map›Paper›PMID 37485044›Full record

ArticleNanophotonics (Berlin, Germany)2021

Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D

Pushpamali De Silva, Shazia Bano, Brian W Pogue, Kenneth K Wang, Edward V Maytin, Tayyaba Hasan

Open access · goldAbstract read
In one paragraph

Article in Nanophotonics (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. The clinical ionizable lipid SM-102 enhances photochemical immunogenic cell death by verteporfin-conjugated liposomes and improves survival in vivo.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Machine learning in AIRR diagnostics: Advances and applications.Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
  10. Review
  11. Palladium(II)-ComplexedACS omega · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Enhancing antitumour immunity with photodynamic therapy.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
  17. Review
  18. Article
  19. A Physiochemical,ACS applied bio materials · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Pushpamali De SilvaWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.ORCID 0000-0002-0747-5637
Shazia BanoWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.ORCID 0000-0002-8870-3805
Brian W PogueThayer School of Engineering, Dartmouth College, Hanover, NH, 03755, USA.
Kenneth K WangDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55905, USA.
Edward V MaytinDepartments of Dermatology and Biomedical Engineering, Cleveland Clinic, Cleveland, OH, 44195, USA.
Tayyaba HasanWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom Street, BAR 314A, Boston, MA, 02114, USA.ORCID 0000-0003-0871-6057
Harvard University · USCleveland Clinic · USDartmouth College · USMayo Clinic in Arizona · US

Funding

Small Molecule Enhancers of Photodynamic Therapy for Skin CancerP01CA084203 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Brian William Pogue · 2001 to 2026
$27.9M
Dual function theranostic constructs for photoacoustic guided surgery and photodynamic therapyR01CA231606 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HASAN, TAYYABA · 2019 to 2025
$3.1M
NCI NIH HHS P01 CA084203NCI NIH HHS R01 CA231606
6 · The paper itself

Abstract

Photodynamic priming (

Indexed as

immunogenic cell deathmultitargetingphoto-dynamic therapyphotoimmuno-nano-conjugatesT cell primingtumor heterogeneity

Identifiers

PMID37485044
PMCPMC10361703
OpenAlexW3196254557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.